Evaluation of the synthetic somatostatin analogue SMS 201-995 in patients with hypoglycaemia associated with hepatocellular carcinoma.
作者信息
Joffe B I, Kew M C, Panz V R, Kalk W J, Shires R, Wing J, Seftel H C
机构信息
Department of Medicine, University of the Witwatersrand Medical School, Parktown, Johannesburg, South Africa.
出版信息
Br J Cancer. 1988 Jul;58(1):91-2. doi: 10.1038/bjc.1988.170.
Abstract
摘要
相似文献
1
Evaluation of the synthetic somatostatin analogue SMS 201-995 in patients with hypoglycaemia associated with hepatocellular carcinoma.合成生长抑素类似物SMS 201-995对肝细胞癌伴低血糖患者的疗效评估。
Br J Cancer. 1988 Jul;58(1):91-2. doi: 10.1038/bjc.1988.170.
2
[Hypoglycemia and primary liver cancer. Hormone levels. Action of diazoxide].[低血糖与原发性肝癌。激素水平。二氮嗪的作用]
Rev Med Chir Mal Foie. 1967 Jun;42(3):157-66.
3
Paraneoplastic hypoglycaemia treated with somatostatin analogue SMS 201-995.用生长抑素类似物SMS 201-995治疗副肿瘤性低血糖症。
Eur J Surg Oncol. 1996 Oct;22(5):546-7. doi: 10.1016/s0748-7983(96)93317-x.
4
[Hepatocellular carcinoma complicated by non-islet cell tumor hypoglycemia].肝细胞癌合并非胰岛细胞瘤性低血糖症
Ned Tijdschr Geneeskd. 2002 May 4;146(18):859-62.
5
Studies on hypoglycaemia in primary carcinoma of the liver. A case report and review of pathogenetic mechanisms.
S Afr Med J. 1974 Mar 31;47(12):518-24.
6
[Hypoglycemia and primary cancer of the liver. Hormonal titers. Action of diazoxide].[低血糖与原发性肝癌。激素滴度。二氮嗪的作用]
Bull Mem Soc Med Hop Paris. 1967 Jan 27;118(2):131-8.
7
Octreotide exacerbated fasting hypoglycaemia in a patient with a proinsulinoma; the glucostatic importance of pancreatic glucagon.
Clin Endocrinol (Oxf). 1995 Jul;43(1):117-20; discussion 120-2. doi: 10.1111/j.1365-2265.1995.tb01901.x.
8
Rapid reversal of life-threatening hypoglycaemia with a somatostatin analogue (octreotide). A case report.使用生长抑素类似物（奥曲肽）快速逆转危及生命的低血糖症。病例报告。
S Afr Med J. 1988 Jul 16;74(2):75-6.
9
Primary hepatocellular carcinoma with severe hypoglycemia: involvement of insulin-like growth factors.
Liver. 1992 Apr;12(2):90-3. doi: 10.1111/j.1600-0676.1992.tb00563.x.
10
Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma.餐后高胰岛素血症对人肝细胞癌生长的增强作用。
Gut. 2002 Jul;51(1):100-4. doi: 10.1136/gut.51.1.100.
本文引用的文献
1
Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia.正常受试者、生长障碍患者及胰腺外肿瘤性低血糖患者中胰岛素样生长因子I和II的放射免疫测定
J Clin Invest. 1981 Nov;68(5):1321-30. doi: 10.1172/jci110379.
2
Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia.采用特异性放射受体分析法测定正常个体、生长激素分泌异常患者及肿瘤相关性低血糖患者血清中的胰岛素样生长因子II。
J Clin Endocrinol Metab. 1981 Aug;53(2):289-94. doi: 10.1210/jcem-53-2-289.
3
The riddle of tumour hypoglycaemia revisited.肿瘤性低血糖之谜再探。
Clin Endocrinol Metab. 1980 Jul;9(2):335-60. doi: 10.1016/s0300-595x(80)80037-5.
4
Hypoglycemia associated with non-islet-cell tumor and insulin-like growth factors.与非胰岛细胞瘤及胰岛素样生长因子相关的低血糖症
N Engl J Med. 1981 Dec 10;305(24):1452-5. doi: 10.1056/NEJM198112103052405.
5
SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.SMS 201 - 995：一种非常强效且具选择性的生长抑素八肽类似物，作用持久。
Life Sci. 1982 Sep 13;31(11):1133-40. doi: 10.1016/0024-3205(82)90087-x.
6
Further observations on hypoglycaemia in hepatocellular carcinoma.肝细胞癌低血糖症的进一步观察
Am J Med. 1969 Aug;47(2):220-35. doi: 10.1016/0002-9343(69)90148-x.
7
Tumor hypoglycemia: deficient splanchnic glucose output and deficient glucagon secretion.
Diabetes. 1976 Mar;25(3):202-6. doi: 10.2337/diab.25.3.202.
8
Serum somatomedin and insulin levels in tumor hypoglycemia.肿瘤性低血糖症中的血清生长调节素和胰岛素水平。
J Endocrinol Invest. 1978 Jul;1(3):269-71. doi: 10.1007/BF03350392.
9
Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue.长效生长抑素类似物对胰腺内分泌肿瘤分泌的抑制作用
Lancet. 1979 Oct 13;2(8146):764-7. doi: 10.1016/s0140-6736(79)92115-9.
Zotero 插件